Results

Total Results: 179 records

Showing results for "corporation".

161. Horizon-Scan Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
     December 01, 2011 - AHRQ Healthcare Horizon Scanning System Horizon Scanning Protocol and Operations Manual Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. HHSA290201000006C Prepared by: …

162. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
     May 25, 2021 - TEP #5 Results The reference is unclear: “Corporation DT.

163. Systematic Review on Treatments for Acute Pain: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
     May 01, 2022 - under Contract No. 290- 2015-00009-I and the Southern California Evidence-based Practice Center-RAND Corporation

164. An Evidence Review of Active Surveillance in Men with Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_disposition-comments.pdf
     December 01, 2011 - The Consortium is, a nonprofit corporation, whose mission is to ensure that patients have availability

165. FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
     May 01, 2013 - FRN 27 - Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs Future Research Needs Paper Number 27 Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: Future Research Needs …

166. Options for Developing a Web-Based Forum on Patient Registries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registries-forums_research_0.pdf
     May 01, 2014 - Research (NIH) Industry AMAG Pharmaceuticals Celgene Ground Zero Software IDEA Partnership Intellica Corporation

167. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
     June 01, 2010 - Evidence-based Practice Center Systematic Review Protocol Source: www.effectivehealthcare.ahrq.gov Published Online: June 1, 2010 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa…

168. Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
     March 01, 2012 - Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRIs) for Treating Hypertension Future Research Needs Paper Number 14 Future Research Needs for Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor…

169. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
     November 27, 2017 - Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel Draft r…

170. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Horizon Scanning Protocol and Operations Manual September 2015 Revision AHRQ Healthcare Horizon Scanning System Horizon Scanning Protocol and Operations Manual September 2015 Revision Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road…

171. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
     September 01, 2015 - Horizon Scanning Protocol and Operations Manual September 2015 Revision AHRQ Healthcare Horizon Scanning System Horizon Scanning Protocol and Operations Manual September 2015 Revision Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road…

172. Kidney-Stones-Draft-Appendi-C (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
     January 01, 2024 - None NR NR NR NR Rorer Pharmaceutical Corporation, Kaiser Foundation Hospitals Industry/Other United

173. Disposition of Comments for Treatment To Prevent Fractures in Men and Women With Low Bone Density or Osteoporosis -- Update of a 2007 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
     March 01, 2012 - at least 3 months duration on the use of alendronate to treat or prevent osteoporosis by the Merck Corporation

174. Machine Learning Methods in Systematic Reviews: Identifying Quality Improvement Intervention Evaluations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/machine-learning-quality_research.pdf
     September 01, 2012 - No. 290-2007-10062-I Prepared by: Southern California Evidence-based Practice Center, RAND Corporation

175. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-usability-testing.pdf
     November 01, 2018 - 2016 EPC Type: Evidence Reports EPC Name: Southern California Evidence-based Practice Center—RAND Corporation

176. Asthma-Immunotherapy-2011 Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
     January 01, 2011 - USA fCenters for Disease Control and Prevention, Atlanta, GA, USA gSouthern California EPC, RAND Corporation

177. Lumbar-Fusion-Draft-Report-Appendix-D (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
     January 01, 2019 - Title Appendix D - Evidence Tables Table D-1. KQ 1-4 Table D-1. Evidence tables for randomized controlled trials (RCTs) and nonrandomized studies of interventions (NRSIs) fpr Key Questions (KQs) 1-4: Fusion procedures for degenerative spondylolisthesis RefID KQ Author, Year Parent Study St…

178. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - CERs Report cover Future Research Needs Paper Number 5 Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women This report is based on research conducted by the Oregon Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockv…

179. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - Future Research Needs Document Future Research Needs To Reduce the Risk of Primary Breast Cancer in Women was available for public comment from September 29, 2010, to October 25, 2010. In response to questions and suggestions received, revisions were made in this version to clarify that no incentives were offere…